Immune Efficacy of a Genetically Engineered Vaccine against Lymphocystis Disease Virus: Analysis of Different Immunization Strategies

Here, we report the construction of a vaccine against lymphocystis disease virus (LCDV) using nucleic acid vaccination technology. A fragment of the major capsid protein encoding gene from an LCDV isolated from China (LCDV-cn) was cloned into an eukaryotic expression vector pEGFP-N2, yielding a reco...

Descripción completa

Detalles Bibliográficos
Autores principales: Zheng, Fengrong, Sun, Xiuqin, Wu, Xing'an, Liu, Hongzhan, Li, Jiye, Wu, Suqi, Zhang, Jinxing
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi Publishing Corporation 2011
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3140788/
https://www.ncbi.nlm.nih.gov/pubmed/21789044
http://dx.doi.org/10.1155/2011/729216

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3140788/
https://www.ncbi.nlm.nih.gov/pubmed/21789044
http://dx.doi.org/10.1155/2011/729216

Ejemplares similares